Top

Journal of Medical Case Reports

Published in:

Open Access 01-12-2019 | Retinal Detachment | Case report

Central serous retinopathy associated with topical oral corticosteroid use: a case report

Authors: Preston O’Brien, Ryan C. Young, Shelley Day Ghafoori, C. Armitage Harper, Robert W. Wong

Published in: Journal of Medical Case Reports | Issue 1/2019

Abstract

Background

Oral topical corticosteroid gels are widely used in dental medicine. Case studies of central serous retinopathy have been reported following administration of corticosteroids, but none so far coinciding with the use of topical fluocinonide gel. This case report further contributes to the database of potential risks of corticosteroid use.

Case presentation

A 40-year-old South Asian woman presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in both eyes 1 month after starting treatment with topical fluocinonide 0.05%, a topical oral corticosteroid gel. Her condition resolved 6 months after discontinuing the use of the steroid.

Conclusions

To the best of our knowledge, this is the first case of idiopathic central serous retinopathy associated with the use of oral fluocinonide gel. Discontinuing the use of the steroid may result in resolution of the serous retinal detachment and improvement of visual symptoms. Patients and their doctors who prescribe this medication should be aware of this association.

Hussain D, Gass JD. Idiopathic central serous chorioretinopathy. Indian J Ophthalmol. 1998;46(3):131–7.PubMed

Yannuzzi LA. Type-A behavior and central serous chorioretinopathy. Retina. 1987;7(2):111–31.CrossRef

Thoelen AM, Bernasconi PP, Schmid C, et al. Central serous chorioretinopathy associated with a carcinoma of the adrenal cortex. Retina. 2000;20(1):98–9.CrossRef

Zamir E. Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis. Graefes Arch Clin Exp Ophthalmol. 1997;235(6):339–44.CrossRef

Chumbley LC, Frank RN. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974;77(2):158–60.CrossRef

Carvalho-Recchia CA, Yannuzzi LA, Negrao S, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109(10):1834–7.CrossRef

Harada T, Harada K. Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol. 1985;60(1):37–44.CrossRef

Kao LY. Bilateral serous retinal detachment resembling central serous chorioretinopathy following epidural steroid injection. Retina. 1998;18(5):479–81.CrossRef

Haimovici R, Gragoudas ES, Duker JS, et al. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology. 1997;104(10):1653–60.CrossRef

10.

Baumal CR, Martidis A, Truong SN. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis. Arch Ophthalmol. 2004;122(6):926–8.CrossRef

11.

Mondal LK, Sarkar K, Datta H, et al. Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid. Indian J Ophthalmol. 2005;53(2):132–4.CrossRef

12.

Fernandez CF, Mendoza AJ, Arevalo JF. Central serous chorioretinopathy associated with topical dermal corticosteroids. Retina. 2004;24(3):471–4.CrossRef

13.

Chan LY, Adam RS, Adam DN. Localized topical steroid use and central serous retinopathy. J Dermatol Treat. 2016;27(5):425–6.CrossRef

14.

Ezra N, Taban M, Behroozan D. Central Serous Chorioretinopathy Associated With Topical Corticosteroids in a Patient With Psoriasis. J Drugs Dermatol. 2011;10:918–21.PubMed

15.

Karadimas P, Kapetanios A, Bouzas EA. Central Serous Chorioretinopathy After Local Application of Glucocorticoids for Skin Disorders. Arch Ophthalmol. 2004;122(5):784–6.CrossRef

16.

George S, Balan A. A potential side effect of oral topical steroids: Central serous chorioretinopathy. Indian J Dent Res. 2018;29:107–8.CrossRef

17.

Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431–48.CrossRef

18.

Ciardella AP, Guyer DR, Spitznas M, Yannuzzi LA. Central serous chorioretinopathy. In: Ryan SJ, editor. Retina. St Louis: Mosby Inc; 2001. p. 1153–81. ed 3.

19.

Ehrlich HP, Tarver H, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg. 1973;177:222–7.CrossRef

20.

Basti CP. Regulation of cation transport by low doses of glucocorticoids. J Clin Invest. 1987;80:848–56.

21.

Mudvari SS, Goff MJ, Fu AD, et al. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina. 2007;27(9):1168–73.CrossRef

22.

Chatziralli I, Vlachodimitropoulou A, Daoula C, Vrettou C, Galani E, Theodossiadis G, Theodossiadis P. Eplerenone in the treatment of central serous chorioretinopathy: A review of the literature. Int J Retin Vitr. 2018;4:33.CrossRef

23.

Bousquet E, et al. Spironolactone for nonresolving central serous chorioretinopathy: A randomized controlled crossover study. Retina. 2015;35:2505–15. https://doi.org/10.1097/IAE.0000000000000614.CrossRefPubMedPubMedCentral

24.

Orellana J. Therapy of Central Serous Chorioretinopathy and Diabetic Macular Edema Using NSAIDs. Retin Physician. 2006; https://www.retinalphysician.com/issues/2006/nov-dec/therapy-of-central-serous-chorioretinopathy-and-di. Accessed 7 Aug 2018.

25.

Gass JD. Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(3 Pt 1):456–67.

26.

Inoue M, Kadonosono K, Watanabe Y, et al. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Retina. 2010;30(5):733–8.CrossRef

27.

Lim JW, Kim MU. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):969–74. https://doi.org/10.1007/s00417-010-1581-9. Epub 2010 Dec 8.CrossRefPubMed

28.

Yannuzzi LA, Slakter JS, Kaufman SR, et al. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol. 1992;2(3):103–14.CrossRef

29.

Varoni EM, Molteni A, Sardella A, Carrassi A, Di Candia D, Gigli F, Lodi F, Lodi G. Pharmacokinetics study about topical clobetasol on oral mucosa. J Oral Pathol Med. 2012;41:255–60. https://doi.org/10.1111/j.1600-0714.2011.01087.x.CrossRefPubMed

30.

Routes AE, Drug absorption, distribution and elimination Pharmacokinetics. http://www.columbia.edu/itc/gsas/g9600/2004/GrazianoReadings/Drugabs.pdf. Accessed 5 May 2019.

31.

Plemons JM, Rees TD, Zachariah NY. Absorption of a topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus. Oral Surg Oral Med Oral Pathol. 1990;69(6):688–93. https://doi.org/10.1016/0030-4220(90)90349-W CrossRef

Title: Central serous retinopathy associated with topical oral corticosteroid use: a case report
Authors: Preston O’Brien
Ryan C. Young
Shelley Day Ghafoori
C. Armitage Harper
Robert W. Wong
Publication date: 01-12-2019
Publisher: BioMed Central
Keyword: Retinal Detachment
Published in: Journal of Medical Case Reports / Issue 1/2019
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/s13256-019-2143-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Central serous retinopathy associated with topical oral corticosteroid use: a case report

Abstract

Background

Case presentation

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Severe hypothyroidism presenting as reversible proteinuria: two case reports

Clinical exome sequencing identifies two novel mutations of the SCN1A and SCN2A genes in Moroccan patients with epilepsy: a case series

Neglected intrauterine fetal demise for more than two decades leading to the development of a lithopedion: a case report

Strongyloides stercoralis infection after the use of emergency corticosteroids: a case report on hyperinfection syndrome

Antisynthetase syndrome presenting as interstitial lung disease: a case report

Cluster of differentiation 8 and programmed cell death ligand 1 expression in triple-negative breast cancer combined with autosomal dominant polycystic kidney disease and tuberous sclerosis complex: a case report